Treosulfan

Hematopoietic Stem Cell Transplantation From Haploidentical Donors in Patients With Hematological Malignancies Using a Treosulfan-Based Preparative Regimen

More Information

Trial Status
Accepting patients
Trial Phase
Phase 2
Enrollment
60 patients (estimated)
Sponsors
Fred Hutchinson / University of Washington Cancer Consortium
Collaborators
medac GmbH
Tags
Allogeneic Stem Cell Transplant, Chemotherapy, Radiation Therapy
Trial Type
Treatment
Last Update
10 months ago
SparkCures ID
1419
NCT Identifier
NCT04195633

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print a patient-friendly report to share with your patient.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.